Trojan Bio
PrivateLast Round
Seed
Jan 4, 2024
Est. Valuation
$3M
Total Funding Raised
$315,000
Company Overview
Trojan Bio operates in Healthcare & Life Sciences and is based in Ness Ziona. Its latest recorded funding round was a Seed round in January 2024.
Trojan Bio is a biotechnology company developing a novel class of therapeutic antibodies for the treatment of various cancers by harnessing antiviral immunity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trojan Bio Comparables
Compare Trojan Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VerImmune | 85% | |
| ViVac Pharma | 82% | |
| Biond Biologics | 77% |
For institutional investors. Book with your work email.
Trojan Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 4, 2024 | ||||
| Seed | Oct 19, 2021 |
For institutional investors. Book with your work email.
Trojan Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | Seed |
| Gaingels | Seed |
| Peregrine Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 4, 2024
Raised capital from NFX, Gaingels, and Peregrine Ventures.
- Oct 19, 2021
$315K round led by Peregrine Ventures.
For institutional investors. Book with your work email.
Trojan Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trojan Bio's valuation, stock price, and market status.
Is Trojan Bio a public or private company?
Trojan Bio is a private company.
What is the current stock price of Trojan Bio?
Trojan Bio is a private company, so its shares have no public market price. Caplight tracks Trojan Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trojan Bio worth (valuation)?
Trojan Bio's valuation is estimated at $3.0M based on funding round data.
Can I buy Trojan Bio stock?
Trojan Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trojan Bio's last funding round?
Trojan Bio's most recent funding round was Seed on January 4, 2024.
Who are the main investors in Trojan Bio?
Key investors in Trojan Bio include NFX, Gaingels, Peregrine Ventures.
Will Trojan Bio IPO soon?
No public IPO plans have been announced for Trojan Bio.
How can I track Trojan Bio secondary market activity?
Caplight tracks bids, offers, and trades in Trojan Bio's shares on secondary markets.